TRADING UPDATE
EMBARGOED UNTIL: 0700 HOURS FRIDAY 10 JULY 2009
Bodycote is providing the following trading update ahead of its interim results
announcement on 29 July 2009.
Trading
As has been widely reported, industrial output has continued to decline
globally. In European economies, such as Germany and Sweden, where automotive,
capital goods and general industrial activities predominate, the impact for
Bodycote has been significantly greater than in countries which also have
substantial aerospace and power generation activity, notably the UK and USA. As
announced in the IMS on 27 April 2009, the automotive sector has seen some
recovery but from very low levels. Capital goods and general industrial demand
appears to have stabilised but aerospace and oil & gas demand has continued to
soften.
Consequently, revenue for the continuing business (post the sale of the Testing
division) for the six months to 30 June 2009 is 20% below the same period last
year. On a constant currency basis, revenues for the continuing business are
down 31%. As a result, the Board expects to announce a marginal operating loss
before exceptional items for the half year.
Restructuring
The actions agreed and provided for in 2008 continue to be executed in line
with our expectations. Additional restructuring actions in South America and
Europe have now been put in place, together with further cost cutting measures
over and above those anticipated at the time of the IMS. Details of the cash
cost of all these additional actions, the associated asset write downs, and the
incremental cash savings will be given at the time of the interim results.
Financial Position
Bodycote has a strong balance sheet and continues to focus on reducing capital
expenditure and effective working capital management. Reflecting this, there
was a positive operating cash flow in the first half. As at June 30 net
borrowings stood at £89m, having paid £23m, as expected, in settlement of tax
liabilities related to the sale of the Testing business and having paid the
final dividend for 2008 (£10m) in May instead of July as was the previous
practice.
Outlook
There has to date been some modest improvement in auto demand from the very
depressed levels seen in the early part of the year but customer summer
shutdowns are expected to be longer than those of last year. Aerospace and oil
& gas demand continues to soften. The wide-ranging restructuring plans that are
being actioned are already delivering material cost savings and these will
increase as the year progresses. As a consequence of our short order book and
continuing uncertainty in market conditions visibility is very limited, but if
demand remains at its current depressed levels the Board would anticipate the
outcome for 2009 being materially below recent market EBIT consensus (£24m).
For further information, please contact:
Bodycote plc Tel No: +44 (0)1625 505300
Stephen Harris, Chief Executive
David Landless, Group Finance Director
Financial Dynamics Tel No: +44 (0) 20 7831 3113
Jon Simmons
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.